4 lots of DPT mixte vaccine were produced with whooping-cough vaccine concentrated fluid by fermentor D300. The product was reached WHO and Hanoi National Controlled Centre criterion of safety and efficacy
Antigens, Bacterial ; Pertussis Vaccine

Quality of RP5 pertussis vaccines for National Reference was tested and its potency was also calibrated in comparison with the International Standard of Pertussis Vaccine. The results showed that the candidate for National reference RP5 pertussis vaccine lot was met to the quality requirements after being freeze dried. The homogenicity in dry weight, residual moisture, potency and stability of its potency make it became as the first National Reference standard pertussis.
Pertussis Vaccine ; Vaccines

Using 0.1% formalin for inactivation and detoxification in the production of pertussis vaccine gave good results with 3 experimental lots PM10, PM11, and PM12 had high safety: MWG test was 76%-84.2% higher than control lots 62.4%, LPF test was 32,210-41,200 lower than control lot 58,600. The preliminary findings suggest these 3 experimental lots had less toxicity than standard and control lot. This method can be used in routine pertussis vaccine production
Pertussis Vaccine ; vaccines ; Whooping Cough

After 3 months storage at 4oC and 4 weeks storage at room temperature, 3 lots of monospecific pertussis antiserum of type 1, type 2, type 3 produced in Da Lat Vaccine Institute were still met the requirement of specificity and sensitivity. But they were degraded after 5 weeks of storage at room temperature (24-26oC)
Whooping Cough ; Pertussis Vaccine ; immunization

Absorbed DTP vaccines in the same Lot (produced by IVAC, Nha Trang) were kept at 4°C, -5 +/-10oC, -20°C on 2, 3 and 6 hours. After being thawed completely, the vaccine containers were vigorously shaken and the contents were examined for physical changes. The results showed that the containers kept at 4oC had no physical changes; the containers kept at -5 +/-10oC, 20°C for 6 hours had significant changes such as agglomeration, floccules or granular matter, and sedimented rapidly. It is suggested that structure of aluminum adjuvant in DTP vaccine is changed. The containers kept at -5 +/-10oC, -20°C for 6 hours can be considered as the positive control and the shaking test can be used to determine the previous freezing of adsorbed DTP vaccines.
Diphtheria-Tetanus-Pertussis Vaccine ; Freezing

No abstract available.
Child* ; Diphtheria-Tetanus-Pertussis Vaccine* ; Humans ; Infant*

17 final bulks of pertussis suspension, combined with AlPO4 were evaluated for specific toxicity by MWG test, LPF test and MICRO LAL test. Results showed that: there was relationship between potency and specific toxicity of the vaccine. LPF test was found more reliable than MICRO LAL test when compared to MWG test.
Diphtheria-Tetanus-Pertussis Vaccine ; Whooping Cough ; toxicity

No abstract available.
Animals ; Pertussis Vaccine* ; Rats* ; Streptozocin* ; Whooping Cough*

The pertussis surveillance system has been established since 2009 in Tianjin, and continuously improved over the past 10 years. This system determines the definition and classification of pertussis, establishes simple and feasible sampling methods and laboratory detection methods in clinical practice, standardizes the report management of pertussis cases and the treatment of epidemic situations. After the implementation of the surveillance system, the number of reported pertussis cases increased from 26 in 2009 to 802 in 2017, the number of diagnosed cases increased from 19 in 2009 to 662 in 2017, the reported incidence rate of pertussis increased from 0.16/100 000 in 2009 to 4.28/100 000 in 2017, and the number of medical institutions of reporting perutssis cases increased from 2 in 2009 to 53 in 2017. The specimen collection rate of the reported cases reached up to 93.66%. These results show that the sensitivity of pertussis surveillance has been improved and show that the data from the surveillance system may reflect more precisely the epidemical characteristics of perutssis in Tianjin.
Humans ; Incidence ; Infant ; Pertussis Vaccine ; Whooping Cough

Bordetella pertussis ; immunology ; Consensus ; Humans ; Pertussis Vaccine ; therapeutic use ; Whooping Cough ; immunology ; prevention & control